National Cancer Institute Biospecimen Evidence-Based Practices: Harmonizing Procedures for Nucleic Acid Extraction from Formalin-Fixed, Paraffin-Embedded Tissue

Affiliations

¹ 1 Kelly Government Solutions , Rockville, Maryland.
² 2 Preferred Solutions Group , Arlington, Virginia.
³ 3 Cytogenetics/Molecular Genetics Laboratory at Nationwide Children's Hospital , Columbus, Ohio.
⁴ 4 Biorepositories and Biospecimen Research Branch, Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute , Bethesda, Maryland.
⁵ 5 Department of Genetics, Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill , Chapel Hill, North Carolina.
⁶ 6 Canada's Michael Smith Genome Sciences Center , BC Cancer Agency, Vancouver, Canada .
⁷ 7 Human Genome Sequencing Center , Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.

PMID: 29920119
PMCID: PMC6080192
DOI: 10.1089/bio.2018.0046

National Cancer Institute Biospecimen Evidence-Based Practices: Harmonizing Procedures for Nucleic Acid Extraction from Formalin-Fixed, Paraffin-Embedded Tissue

Sarah R Greytak et al. Biopreserv Biobank. 2018 Aug.

. 2018 Aug;16(4):247-250.

doi: 10.1089/bio.2018.0046. Epub 2018 Jun 19.

Authors

Affiliations

¹ 1 Kelly Government Solutions , Rockville, Maryland.
² 2 Preferred Solutions Group , Arlington, Virginia.
³ 3 Cytogenetics/Molecular Genetics Laboratory at Nationwide Children's Hospital , Columbus, Ohio.
⁴ 4 Biorepositories and Biospecimen Research Branch, Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute , Bethesda, Maryland.
⁵ 5 Department of Genetics, Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill , Chapel Hill, North Carolina.
⁶ 6 Canada's Michael Smith Genome Sciences Center , BC Cancer Agency, Vancouver, Canada .
⁷ 7 Human Genome Sequencing Center , Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.

PMID: 29920119
PMCID: PMC6080192
DOI: 10.1089/bio.2018.0046

No abstract available

PubMed Disclaimer

Conflict of interest statement

No conflicting financial interests exist.

Cited by

Currently Applied Molecular Assays for Identifying ESR1 Mutations in Patients with Advanced Breast Cancer.
Lee N, Park MJ, Song W, Jeon K, Jeong S. Lee N, et al. Int J Mol Sci. 2020 Nov 20;21(22):8807. doi: 10.3390/ijms21228807. Int J Mol Sci. 2020. PMID: 33233830 Free PMC article. Review.
The quality of DNA isolated from autopsy formalin-fixed and formalin-fixed paraffin-embedded tissues: study of 1662 samples.
Vitošević K, Todorović D, Slović Ž, Varljen T, Radaković I, Radojević D, Čanović V, Todorović M. Vitošević K, et al. Mol Biol Rep. 2023 Aug;50(8):6323-6336. doi: 10.1007/s11033-023-08491-5. Epub 2023 Jun 13. Mol Biol Rep. 2023. PMID: 37310548
Molecular Features of Cancers Exhibiting Exceptional Responses to Treatment.
Wheeler DA, Takebe N, Hinoue T, Hoadley KA, Cardenas MF, Hamilton AM, Laird PW, Wang L, Johnson A, Dewal N, Miller V, Piñeyro D, Castro de Moura M, Esteller M, Shen H, Zenklusen JC, Tarnuzzer R, McShane LM, Tricoli JV, Williams PM, Lubensky I, O'Sullivan-Coyne G, Kohn EC, Little RF, White J, Malik S, Harris L, Weil C, Chen AP, Karlovich C, Rodgers B, Shankar L, Jacobs P, Nolan T, Hu J, Muzny DM, Doddapaneni H, Korchina V, Gastier-Foster J, Bowen J, Leraas K, Edmondson EF, Doroshow JH, Conley BA, Ivy SP, Staudt LM. Wheeler DA, et al. Cancer Cell. 2021 Jan 11;39(1):38-53.e7. doi: 10.1016/j.ccell.2020.10.015. Epub 2020 Nov 19. Cancer Cell. 2021. PMID: 33217343 Free PMC article.

References

1. Poste G. Bring on the biomarkers. Nature 2011;469:156–157 - PubMed
1. Taube SE, Clark GM, Dancey JE, et al. . A perspective on challenges and issues in biomarker development and drug and biomarker codevelopment. J Natl Cancer Inst 2009;101:1453–1463 - PMC - PubMed
1. de Gramont A, Watson S, Ellis LM, et al. . Pragmatic issues in biomarker evaluation for targeted therapies in cancer. Nat Rev Clin Oncol 2015;12:197–212 - PubMed
1. Engel KB, Vaught J, Moore HM. National Cancer Institute Biospecimen Evidence-Based Practices: A novel approach to pre-analytical standardization. Biopreserv Biobank 2014;12:148–150 - PMC - PubMed
1. Bass BP, Engel KB, Greytak SR, et al. . A review of pre-analytical factors affecting molecular, protein, and morphological analysis of formalin-fixed, paraffin-embedded tissue. Arch Pathol Lab Med 2014;138:1520–1530 - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

National Cancer Institute Biospecimen Evidence-Based Practices: Harmonizing Procedures for Nucleic Acid Extraction from Formalin-Fixed, Paraffin-Embedded Tissue

Affiliations

National Cancer Institute Biospecimen Evidence-Based Practices: Harmonizing Procedures for Nucleic Acid Extraction from Formalin-Fixed, Paraffin-Embedded Tissue

Authors

Affiliations

Conflict of interest statement

Similar articles

Cited by

References

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Conflict of interest statement

Similar articles

Cited by

References

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources